Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03680118
Other study ID # cairouimplant masters
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date December 15, 2018
Est. completion date December 2019

Study information

Verified date November 2018
Source Cairo University
Contact Mostafa Shawky Shaheen, BDS
Phone +201118153852
Email dentshaheen@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Atrophic ridge augmentation utilizing guided bone regeneration (GBR) has become a major treatment option to provide optimal bone support for osseointegrated dental implants. GBR was initially employed to treat simple defects, including dehiscence and fenestration defects. In addition, GBR has been utilized for horizontal and vertical ridge augmentations and has demonstrated reproducible outcomes, with high implant survival rates and low complication rates. The results of recent clinical and histologic studies of ridge augmentation with GBR indicated that autogenous bone graft may be a suitable material for staged localized ridge augmentation in both horizontal and vertical augmentations. The main advantages of autogenous grafts are their osteogenic, osteoinductive and osteoconductive capabilities. Because of these qualities, autogenous grafts are considered by many to be the gold standard for bone regeneration


Description:

The GBR Procedure requires to place a barrier between the bone graft and the surrounding soft tissues. This blocks the fast-duplicating connective and epithelial cells from colonizing the regenerating site.

Collagen membranes have been successfully used as a barrier membrane in clinical practice.

They have the advantage of being resorbable and pose less post-operative complications. On the other hand, collagen membranes are not rigid, causing a difficulty in maintaining the vertical height of the particulate bone graft placed onto the ridge.

Alternatively, titanium meshes have been used with success in clinical practice and display both advantages and disadvantages. They provide tenting effect thanks to their rigidity and, being moldable, can be easily given the shape needed to cover the defect.

However they must be removed, not resorbable, require time-consuming shaping and pose complications as flap dehiscence.

Choice of the comparator:

Current studies have shown that using titanium mesh as a barrier to protect the bone graft during GBR can be considered successful in terms of vertical bone gain.

There might be variable in other findings which could be attributed to differences in the methodology, such as using other membranes over the titanium mesh (collagen or PTFE membranes).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date December 2019
Est. primary completion date November 2019
Accepts healthy volunteers No
Gender All
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- Adult patients with edentulous posterior mandible.

- Both sexes.

- No intraoral soft and hard tissue pathology.

- No systemic condition that contraindicate implant placement.

- Residual alveolar bone height more than 6 mm (7-9 mm) and less than 12 mm.

Exclusion Criteria:

- Presence of fenestrations or dehiscence of the residual ridge.

- Heavy smokers more than 20 cigarettes per day.

- Patients with systemic disease that may affect normal healing.

- Psychiatric problems

- Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.

Study Design


Related Conditions & MeSH terms

  • Posterior Mandible With Deficient Ridge Height

Intervention

Device:
autogenous rings with GBR and autogenous graft with ti-mesh
Autogenous Onlay ring block harvested from either mandibular ramus or chin will be placed over the defected site and fixed using titanium screws (1.6mm diameter) and then GBR using autogenous particulate will be placed around and over the blocks and covered with a resorbable bilayer collagen membrane (Bio-Gide®, Geistlich, USA) Autogenous bone graft will be placed on the defected site and covered by a titanium mesh which will be fixed by titanium screws. Flap advancement will be acquired by releasing the mylohyoid muscle attachment from the lingual flap and periosteal releasing incision for the buccal flap to provide tension free closure. The flap will then be copiously irrigated with saline in preparation for closure. The flap will then be closed using horizontal mattress and interrupted 4/0 polypropylene sutures.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Outcome

Type Measure Description Time frame Safety issue
Primary vertical bone gain the amount of vertical bone gain will be measured using cone beam computed tomography 6 month